39714451|t|A Self-Reinforced "Microglia Energy Modulator" for Synergistic Amyloid-beta Clearance in Alzheimer's Disease Model.
39714451|a|Microglial phagocytosis is a highly energy-consuming process that plays critical roles in clearing neurotoxic amyloid-beta (Abeta) in Alzheimer's disease (AD). However, microglial metabolism is defective overall in AD, thereby undermining microglial phagocytic functions. Herein, we repurpose the existing antineoplastic drug lonidamine (LND) conjugated with hollow mesoporous Prussian blue (HMPB) as a "microglial energy modulator" (termed LND@HMPB-T7) for safe and synergistic Abeta clearance. The modified blood-brain barrier penetrating heptapeptide (T7) enables efficient transport of LND@HMPB-T7 to the AD brain. LND in LND@HMPB-T7 could fuel Abeta phagocytosis by stimulating microglial adenosine triphosphate (ATP) production, whereas HMPB with catalase and superoxide dismutase-mimicking activities substantially alleviates the mitochondrial side effects commonly associated with LND and thus further enhances ATP production. The synergism of LND and nanozyme affords a high microglial Abeta clearance efficacy without triggering mitochondrial dysfunction. In vivo experiments ascertain that LND@HMPB-T7 could synergistically promote phagocytic clearance of Abeta, relieve neuroinflammation and ameliorate cognitive function in AD mice. These findings indicate that LND@HMPB-T7 holds tremendous clinical potential as a repurposed drug for AD treatment.
39714451	63	75	Amyloid-beta	Gene	351
39714451	89	108	Alzheimer's Disease	Disease	MESH:D000544
39714451	215	225	neurotoxic	Disease	MESH:D020258
39714451	226	238	amyloid-beta	Gene	351
39714451	240	245	Abeta	Gene	351
39714451	250	269	Alzheimer's disease	Disease	MESH:D000544
39714451	271	273	AD	Disease	MESH:D000544
39714451	331	333	AD	Disease	MESH:D000544
39714451	442	452	lonidamine	Chemical	MESH:C016371
39714451	454	457	LND	Chemical	MESH:C016371
39714451	493	506	Prussian blue	Chemical	MESH:C000170
39714451	508	512	HMPB	Chemical	-
39714451	557	568	LND@HMPB-T7	Chemical	-
39714451	595	600	Abeta	Gene	351
39714451	657	669	heptapeptide	Chemical	-
39714451	706	717	LND@HMPB-T7	Chemical	-
39714451	725	727	AD	Disease	MESH:D000544
39714451	735	738	LND	Chemical	MESH:C016371
39714451	742	753	LND@HMPB-T7	Disease	MESH:D018329
39714451	765	770	Abeta	Gene	351
39714451	810	832	adenosine triphosphate	Chemical	MESH:D000255
39714451	834	837	ATP	Chemical	MESH:D000255
39714451	859	863	HMPB	Chemical	-
39714451	869	877	catalase	Gene	847
39714451	953	979	mitochondrial side effects	Disease	MESH:D064420
39714451	1005	1008	LND	Chemical	MESH:C016371
39714451	1035	1038	ATP	Chemical	MESH:D000255
39714451	1068	1071	LND	Chemical	MESH:C016371
39714451	1076	1084	nanozyme	Chemical	-
39714451	1111	1116	Abeta	Gene	351
39714451	1155	1180	mitochondrial dysfunction	Disease	MESH:D028361
39714451	1217	1228	LND@HMPB-T7	Chemical	-
39714451	1283	1288	Abeta	Gene	351
39714451	1298	1315	neuroinflammation	Disease	MESH:D000090862
39714451	1353	1355	AD	Disease	MESH:D000544
39714451	1356	1360	mice	Species	10090
39714451	1464	1466	AD	Disease	MESH:D000544
39714451	Positive_Correlation	MESH:C016371	MESH:D064420
39714451	Association	MESH:D064420	847
39714451	Association	MESH:D000255	847
39714451	Association	MESH:C000170	MESH:C016371
39714451	Negative_Correlation	MESH:C016371	351
39714451	Association	MESH:D000255	351
39714451	Association	MESH:D000544	351
39714451	Association	MESH:D020258	351
39714451	Association	MESH:D018329	351
39714451	Positive_Correlation	MESH:C016371	MESH:D000255
39714451	Association	MESH:C016371	847
39714451	Positive_Correlation	MESH:D000255	MESH:D018329

